nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—Increased Diuresis at Loop of Henle—Furosemide—dilated cardiomyopathy	0.31	1	CiPCiCtD
Bumetanide—Furosemide—dilated cardiomyopathy	0.26	1	CrCtD
Bumetanide—chronic kidney failure—Furosemide—dilated cardiomyopathy	0.144	1	CpDpCtD
Bumetanide—Indapamide—Furosemide—dilated cardiomyopathy	0.129	1	CrCrCtD
Bumetanide—SLC12A1—Furosemide—dilated cardiomyopathy	0.0199	0.15	CbGbCtD
Bumetanide—CA14—Furosemide—dilated cardiomyopathy	0.0155	0.117	CbGbCtD
Bumetanide—CA5A—Furosemide—dilated cardiomyopathy	0.0148	0.111	CbGbCtD
Bumetanide—CA7—Furosemide—dilated cardiomyopathy	0.0129	0.0968	CbGbCtD
Bumetanide—CA5B—Furosemide—dilated cardiomyopathy	0.0129	0.0968	CbGbCtD
Bumetanide—CA12—Furosemide—dilated cardiomyopathy	0.011	0.0831	CbGbCtD
Bumetanide—CA9—Furosemide—dilated cardiomyopathy	0.011	0.0831	CbGbCtD
Bumetanide—CA4—Furosemide—dilated cardiomyopathy	0.00971	0.0731	CbGbCtD
Bumetanide—SLC22A11—Furosemide—dilated cardiomyopathy	0.00848	0.0638	CbGbCtD
Bumetanide—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.00829	0.0624	CbGbCtD
Bumetanide—SLC22A8—Furosemide—dilated cardiomyopathy	0.00493	0.0371	CbGbCtD
Bumetanide—SLC22A6—Furosemide—dilated cardiomyopathy	0.00343	0.0258	CbGbCtD
Bumetanide—CA5B—sinoatrial node—dilated cardiomyopathy	0.00249	0.462	CbGeAlD
Bumetanide—Hypochloraemia—Furosemide—dilated cardiomyopathy	0.00152	0.116	CcSEcCtD
Bumetanide—Diuresis—Furosemide—dilated cardiomyopathy	0.000759	0.0578	CcSEcCtD
Bumetanide—CFTR—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000523	0.103	CbGpPWpGaD
Bumetanide—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.000387	0.0295	CcSEcCtD
Bumetanide—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000383	0.0754	CbGpPWpGaD
Bumetanide—Furosemide—SLC22A5—dilated cardiomyopathy	0.000383	1	CrCbGaD
Bumetanide—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000348	0.0684	CbGpPWpGaD
Bumetanide—SLC12A2—cardiac ventricle—dilated cardiomyopathy	0.000339	0.0627	CbGeAlD
Bumetanide—Azotaemia—Lisinopril—dilated cardiomyopathy	0.000331	0.0252	CcSEcCtD
Bumetanide—SLC12A4—heart—dilated cardiomyopathy	0.000322	0.0597	CbGeAlD
Bumetanide—SLC12A2—myocardium—dilated cardiomyopathy	0.000319	0.059	CbGeAlD
Bumetanide—CA14—cardiac ventricle—dilated cardiomyopathy	0.000317	0.0586	CbGeAlD
Bumetanide—Cholestasis—Furosemide—dilated cardiomyopathy	0.00031	0.0236	CcSEcCtD
Bumetanide—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000292	0.0575	CbGpPWpGaD
Bumetanide—Glycosuria—Furosemide—dilated cardiomyopathy	0.000291	0.0221	CcSEcCtD
Bumetanide—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.000287	0.0219	CcSEcCtD
Bumetanide—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000283	0.0215	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000283	0.0215	CcSEcCtD
Bumetanide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.000254	0.0193	CcSEcCtD
Bumetanide—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000247	0.0188	CcSEcCtD
Bumetanide—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.000244	0.048	CbGpPWpGaD
Bumetanide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00024	0.0183	CcSEcCtD
Bumetanide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00024	0.0183	CcSEcCtD
Bumetanide—Renal failure—Spironolactone—dilated cardiomyopathy	0.000238	0.0181	CcSEcCtD
Bumetanide—SLC12A2—heart—dilated cardiomyopathy	0.000223	0.0412	CbGeAlD
Bumetanide—CA14—heart—dilated cardiomyopathy	0.000208	0.0385	CbGeAlD
Bumetanide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000205	0.0156	CcSEcCtD
Bumetanide—Polyuria—Furosemide—dilated cardiomyopathy	0.000195	0.0148	CcSEcCtD
Bumetanide—SLC12A2—cardiac atrium—dilated cardiomyopathy	0.00019	0.0352	CbGeAlD
Bumetanide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000182	0.0138	CcSEcCtD
Bumetanide—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000179	0.0136	CcSEcCtD
Bumetanide—CA14—cardiac atrium—dilated cardiomyopathy	0.000178	0.0329	CbGeAlD
Bumetanide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000172	0.0131	CcSEcCtD
Bumetanide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000169	0.0129	CcSEcCtD
Bumetanide—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00016	0.0122	CcSEcCtD
Bumetanide—Dehydration—Furosemide—dilated cardiomyopathy	0.000159	0.0121	CcSEcCtD
Bumetanide—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000156	0.0118	CcSEcCtD
Bumetanide—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000154	0.0117	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000154	0.0117	CcSEcCtD
Bumetanide—CA4—cardiac ventricle—dilated cardiomyopathy	0.000153	0.0283	CbGeAlD
Bumetanide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000151	0.0115	CcSEcCtD
Bumetanide—CA5B—heart—dilated cardiomyopathy	0.000145	0.0269	CbGeAlD
Bumetanide—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000145	0.011	CcSEcCtD
Bumetanide—CA4—myocardium—dilated cardiomyopathy	0.000144	0.0266	CbGeAlD
Bumetanide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000133	0.0101	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000131	0.00994	CcSEcCtD
Bumetanide—Renal failure—Furosemide—dilated cardiomyopathy	0.000129	0.00986	CcSEcCtD
Bumetanide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000129	0.0098	CcSEcCtD
Bumetanide—Sweating—Furosemide—dilated cardiomyopathy	0.000126	0.00961	CcSEcCtD
Bumetanide—CA5B—cardiac atrium—dilated cardiomyopathy	0.000124	0.023	CbGeAlD
Bumetanide—Urticaria—Spironolactone—dilated cardiomyopathy	0.000123	0.00934	CcSEcCtD
Bumetanide—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00012	0.00914	CcSEcCtD
Bumetanide—Dehydration—Lisinopril—dilated cardiomyopathy	0.000119	0.00908	CcSEcCtD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000116	0.0227	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000116	0.0227	CbGpPWpGaD
Bumetanide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000115	0.00879	CcSEcCtD
Bumetanide—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000115	0.00879	CcSEcCtD
Bumetanide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000112	0.00851	CcSEcCtD
Bumetanide—Pruritus—Spironolactone—dilated cardiomyopathy	0.000109	0.00832	CcSEcCtD
Bumetanide—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000109	0.00827	CcSEcCtD
Bumetanide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000106	0.00804	CcSEcCtD
Bumetanide—Dizziness—Spironolactone—dilated cardiomyopathy	0.000102	0.00777	CcSEcCtD
Bumetanide—CA4—heart—dilated cardiomyopathy	0.0001	0.0186	CbGeAlD
Bumetanide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.0001	0.00761	CcSEcCtD
Bumetanide—Muscle spasms—Furosemide—dilated cardiomyopathy	9.89e-05	0.00753	CcSEcCtD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.83e-05	0.0193	CbGpPWpGaD
Bumetanide—Vomiting—Spironolactone—dilated cardiomyopathy	9.81e-05	0.00747	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	9.8e-05	0.00746	CcSEcCtD
Bumetanide—Rash—Spironolactone—dilated cardiomyopathy	9.73e-05	0.00741	CcSEcCtD
Bumetanide—Dermatitis—Spironolactone—dilated cardiomyopathy	9.72e-05	0.0074	CcSEcCtD
Bumetanide—Renal failure—Lisinopril—dilated cardiomyopathy	9.71e-05	0.00739	CcSEcCtD
Bumetanide—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	9.69e-05	0.0191	CbGpPWpGaD
Bumetanide—Headache—Spironolactone—dilated cardiomyopathy	9.67e-05	0.00736	CcSEcCtD
Bumetanide—Sweating—Lisinopril—dilated cardiomyopathy	9.47e-05	0.00721	CcSEcCtD
Bumetanide—Vertigo—Furosemide—dilated cardiomyopathy	9.25e-05	0.00704	CcSEcCtD
Bumetanide—Leukopenia—Furosemide—dilated cardiomyopathy	9.21e-05	0.00701	CcSEcCtD
Bumetanide—Nausea—Spironolactone—dilated cardiomyopathy	9.17e-05	0.00698	CcSEcCtD
Bumetanide—CA4—cardiac atrium—dilated cardiomyopathy	8.58e-05	0.0159	CbGeAlD
Bumetanide—Dry mouth—Furosemide—dilated cardiomyopathy	8.57e-05	0.00652	CcSEcCtD
Bumetanide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	8.39e-05	0.00639	CcSEcCtD
Bumetanide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	8.22e-05	0.00626	CcSEcCtD
Bumetanide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	8.12e-05	0.00618	CcSEcCtD
Bumetanide—Hypotension—Furosemide—dilated cardiomyopathy	7.85e-05	0.00598	CcSEcCtD
Bumetanide—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	7.67e-05	0.0151	CbGpPWpGaD
Bumetanide—Muscle spasms—Lisinopril—dilated cardiomyopathy	7.42e-05	0.00565	CcSEcCtD
Bumetanide—Fatigue—Furosemide—dilated cardiomyopathy	7.24e-05	0.00551	CcSEcCtD
Bumetanide—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	6.96e-05	0.0137	CbGpPWpGaD
Bumetanide—Vertigo—Lisinopril—dilated cardiomyopathy	6.94e-05	0.00528	CcSEcCtD
Bumetanide—Leukopenia—Lisinopril—dilated cardiomyopathy	6.91e-05	0.00526	CcSEcCtD
Bumetanide—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	6.87e-05	0.00523	CcSEcCtD
Bumetanide—Urticaria—Furosemide—dilated cardiomyopathy	6.67e-05	0.00508	CcSEcCtD
Bumetanide—Abdominal pain—Furosemide—dilated cardiomyopathy	6.64e-05	0.00505	CcSEcCtD
Bumetanide—Arthralgia—Lisinopril—dilated cardiomyopathy	6.57e-05	0.005	CcSEcCtD
Bumetanide—Chest pain—Lisinopril—dilated cardiomyopathy	6.57e-05	0.005	CcSEcCtD
Bumetanide—Dry mouth—Lisinopril—dilated cardiomyopathy	6.43e-05	0.00489	CcSEcCtD
Bumetanide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	6.17e-05	0.0047	CcSEcCtD
Bumetanide—PTGS2—heart—dilated cardiomyopathy	6.14e-05	0.0114	CbGeAlD
Bumetanide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	6.09e-05	0.00464	CcSEcCtD
Bumetanide—CFTR—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.04e-05	0.0119	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.04e-05	0.0119	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.04e-05	0.0119	CbGpPWpGaD
Bumetanide—Asthenia—Furosemide—dilated cardiomyopathy	6.03e-05	0.00459	CcSEcCtD
Bumetanide—Pruritus—Furosemide—dilated cardiomyopathy	5.94e-05	0.00452	CcSEcCtD
Bumetanide—Hypotension—Lisinopril—dilated cardiomyopathy	5.89e-05	0.00448	CcSEcCtD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.87e-05	0.0116	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	5.85e-05	0.0115	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.84e-05	0.0115	CbGpPWpGaD
Bumetanide—Diarrhoea—Furosemide—dilated cardiomyopathy	5.75e-05	0.00438	CcSEcCtD
Bumetanide—Dizziness—Furosemide—dilated cardiomyopathy	5.55e-05	0.00423	CcSEcCtD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.46e-05	0.0107	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.46e-05	0.0107	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.46e-05	0.0107	CbGpPWpGaD
Bumetanide—Fatigue—Lisinopril—dilated cardiomyopathy	5.43e-05	0.00414	CcSEcCtD
Bumetanide—Vomiting—Furosemide—dilated cardiomyopathy	5.34e-05	0.00407	CcSEcCtD
Bumetanide—Rash—Furosemide—dilated cardiomyopathy	5.3e-05	0.00403	CcSEcCtD
Bumetanide—Dermatitis—Furosemide—dilated cardiomyopathy	5.29e-05	0.00403	CcSEcCtD
Bumetanide—Headache—Furosemide—dilated cardiomyopathy	5.26e-05	0.00401	CcSEcCtD
Bumetanide—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	5.15e-05	0.00392	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.13e-05	0.0101	CbGpPWpGaD
Bumetanide—Urticaria—Lisinopril—dilated cardiomyopathy	5.01e-05	0.00381	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.99e-05	0.00983	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.99e-05	0.00983	CbGpPWpGaD
Bumetanide—Nausea—Furosemide—dilated cardiomyopathy	4.99e-05	0.0038	CcSEcCtD
Bumetanide—Abdominal pain—Lisinopril—dilated cardiomyopathy	4.98e-05	0.00379	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	4.88e-05	0.00961	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.64e-05	0.00914	CbGpPWpGaD
Bumetanide—Asthenia—Lisinopril—dilated cardiomyopathy	4.52e-05	0.00344	CcSEcCtD
Bumetanide—Pruritus—Lisinopril—dilated cardiomyopathy	4.46e-05	0.00339	CcSEcCtD
Bumetanide—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.31e-05	0.00328	CcSEcCtD
Bumetanide—Dizziness—Lisinopril—dilated cardiomyopathy	4.17e-05	0.00317	CcSEcCtD
Bumetanide—Vomiting—Lisinopril—dilated cardiomyopathy	4.01e-05	0.00305	CcSEcCtD
Bumetanide—Rash—Lisinopril—dilated cardiomyopathy	3.97e-05	0.00303	CcSEcCtD
Bumetanide—Dermatitis—Lisinopril—dilated cardiomyopathy	3.97e-05	0.00302	CcSEcCtD
Bumetanide—Headache—Lisinopril—dilated cardiomyopathy	3.95e-05	0.00301	CcSEcCtD
Bumetanide—Nausea—Lisinopril—dilated cardiomyopathy	3.74e-05	0.00285	CcSEcCtD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.7e-05	0.00728	CbGpPWpGaD
Bumetanide—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	3.54e-05	0.00696	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	3.49e-05	0.00686	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.48e-05	0.00685	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	3.16e-05	0.00623	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.05e-05	0.00601	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.97e-05	0.00584	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.97e-05	0.00584	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.76e-05	0.00543	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	2.67e-05	0.00525	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	2.66e-05	0.00523	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	2.36e-05	0.00465	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ANKRD1—dilated cardiomyopathy	2.34e-05	0.0046	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ANKRD1—dilated cardiomyopathy	2.28e-05	0.00449	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	2.22e-05	0.00437	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TAZ—dilated cardiomyopathy	2.2e-05	0.00433	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TAZ—dilated cardiomyopathy	2.14e-05	0.00422	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ANKRD1—dilated cardiomyopathy	2.13e-05	0.00419	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ANKRD1—dilated cardiomyopathy	2.13e-05	0.00419	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TAZ—dilated cardiomyopathy	2e-05	0.00394	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TAZ—dilated cardiomyopathy	2e-05	0.00394	CbGpPWpGaD
Bumetanide—CA14—Metabolism—SDHA—dilated cardiomyopathy	1.99e-05	0.00391	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ANKRD1—dilated cardiomyopathy	1.97e-05	0.00388	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—SDHA—dilated cardiomyopathy	1.94e-05	0.00381	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TAZ—dilated cardiomyopathy	1.85e-05	0.00365	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	1.85e-05	0.00364	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	1.83e-05	0.00359	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.82e-05	0.00358	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.82e-05	0.00358	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—SDHA—dilated cardiomyopathy	1.81e-05	0.00356	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SDHA—dilated cardiomyopathy	1.81e-05	0.00356	CbGpPWpGaD
Bumetanide—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	1.78e-05	0.0035	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.77e-05	0.00349	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.77e-05	0.00349	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	1.73e-05	0.0034	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.71e-05	0.00337	CbGpPWpGaD
Bumetanide—CA12—Metabolism—SDHA—dilated cardiomyopathy	1.68e-05	0.0033	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.65e-05	0.00325	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ANKRD1—dilated cardiomyopathy	1.65e-05	0.00324	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.65e-05	0.00324	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.61e-05	0.00316	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.61e-05	0.00316	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ANKRD1—dilated cardiomyopathy	1.57e-05	0.00309	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TAZ—dilated cardiomyopathy	1.55e-05	0.00305	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	1.53e-05	0.00301	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.49e-05	0.00294	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TAZ—dilated cardiomyopathy	1.48e-05	0.00291	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	1.45e-05	0.00285	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SDHA—dilated cardiomyopathy	1.4e-05	0.00276	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.39e-05	0.00273	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.35e-05	0.00266	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.35e-05	0.00266	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SDHA—dilated cardiomyopathy	1.34e-05	0.00263	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—SOD2—dilated cardiomyopathy	1.28e-05	0.00251	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ANKRD1—dilated cardiomyopathy	1.27e-05	0.0025	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.26e-05	0.00247	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.23e-05	0.00243	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—GPX1—dilated cardiomyopathy	1.22e-05	0.0024	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.2e-05	0.00236	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.2e-05	0.00236	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TAZ—dilated cardiomyopathy	1.19e-05	0.00235	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.19e-05	0.00234	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.19e-05	0.00234	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.19e-05	0.00234	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	1.19e-05	0.00233	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.16e-05	0.00228	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	1.16e-05	0.00228	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	1.13e-05	0.00222	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.13e-05	0.00222	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.13e-05	0.00222	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.12e-05	0.0022	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.1e-05	0.00216	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SDHA—dilated cardiomyopathy	1.08e-05	0.00213	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	1.08e-05	0.00212	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.05e-05	0.00206	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.03e-05	0.00203	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.00199	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.55e-06	0.00168	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.32e-06	0.00164	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	8.21e-06	0.00161	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	8.11e-06	0.0016	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	7.93e-06	0.00156	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	7.62e-06	0.0015	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	7.55e-06	0.00149	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.49e-06	0.00147	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	7.06e-06	0.00139	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	6.89e-06	0.00136	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.02e-06	0.00119	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.9e-06	0.00116	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.69e-06	0.00112	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.58e-06	0.0011	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GPX1—dilated cardiomyopathy	5.4e-06	0.00106	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GPX1—dilated cardiomyopathy	5.26e-06	0.00104	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CD36—dilated cardiomyopathy	5.26e-06	0.00104	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CD36—dilated cardiomyopathy	5.13e-06	0.00101	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GPX1—dilated cardiomyopathy	4.92e-06	0.000967	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GPX1—dilated cardiomyopathy	4.92e-06	0.000967	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	4.9e-06	0.000964	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CD36—dilated cardiomyopathy	4.79e-06	0.000942	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CD36—dilated cardiomyopathy	4.79e-06	0.000942	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AGT—dilated cardiomyopathy	4.74e-06	0.000932	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AGT—dilated cardiomyopathy	4.62e-06	0.000909	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	4.6e-06	0.000906	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GPX1—dilated cardiomyopathy	4.55e-06	0.000896	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.49e-06	0.000884	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CD36—dilated cardiomyopathy	4.43e-06	0.000873	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AGT—dilated cardiomyopathy	4.31e-06	0.000848	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AGT—dilated cardiomyopathy	4.31e-06	0.000848	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.21e-06	0.000828	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	4.16e-06	0.000819	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.1e-06	0.000806	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AGT—dilated cardiomyopathy	3.99e-06	0.000786	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPX1—dilated cardiomyopathy	3.81e-06	0.000749	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	3.73e-06	0.000734	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CD36—dilated cardiomyopathy	3.71e-06	0.00073	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.7e-06	0.000728	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.69e-06	0.000726	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPX1—dilated cardiomyopathy	3.63e-06	0.000715	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.59e-06	0.000707	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.55e-06	0.000699	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CD36—dilated cardiomyopathy	3.54e-06	0.000696	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AGT—dilated cardiomyopathy	3.34e-06	0.000657	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.26e-06	0.000642	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AGT—dilated cardiomyopathy	3.18e-06	0.000627	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX1—dilated cardiomyopathy	2.93e-06	0.000577	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD36—dilated cardiomyopathy	2.86e-06	0.000562	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.74e-06	0.000539	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AGT—dilated cardiomyopathy	2.57e-06	0.000506	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NPPA—dilated cardiomyopathy	2.55e-06	0.000501	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.54e-06	0.0005	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.54e-06	0.0005	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.47e-06	0.000487	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PSEN2—dilated cardiomyopathy	2.46e-06	0.000485	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.43e-06	0.000479	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.42e-06	0.000476	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.29e-06	0.00045	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.23e-06	0.000438	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.87e-06	0.000369	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.82e-06	0.000359	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	1.64e-06	0.000323	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.24e-06	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.13e-06	0.000223	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD36—dilated cardiomyopathy	1.1e-06	0.000217	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AGT—dilated cardiomyopathy	9.92e-07	0.000195	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RAF1—dilated cardiomyopathy	8.22e-07	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.64e-07	0.000111	CbGpPWpGaD
